Nitric oxide nanoparticle technology: A novel antimicrobial agent in the context of current treatment of skin and soft tissue infection

Journal of Clinical and Aesthetic Dermatology

Volumn 3, Issue 6, 2010, Pages 45-50

  Englande, Laura ^a   Friedman, Adam ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACITRACIN; CADEXOMER IODINE; CEFAZOLIN; CHLORHEXIDINE; CLOXACILLIN; DIAZENIUMDIOLATE; DICLOXACILLIN; FLUCLOXACILLIN; HYDROGEN PEROXIDE; IODINE; METICILLIN; NAFCILLIN; NEOMYCIN; NEOSPORIN; NITRIC OXIDE; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYSPORIN; PSEUDOMONIC ACID; S NITROSOTHIOL; SILVER; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; VANCOMYCIN; ZEOLITE;

ANAPHYLAXIS; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BURN; CONTACT DERMATITIS; DEBRIDEMENT; DRUG EFFICACY; ENTEROBACTER; ERADICATION THERAPY; ESCHERICHIA COLI; HONEY; HOSPITAL INFECTION; HUMAN; HYPERSENSITIVITY REACTION; INFECTION PREVENTION; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PYODERMA; SERRATIA MARCESCENS; SKIN ALLERGY; SKIN DISEASE; SKIN INFECTION; SOFT TISSUE INFECTION; SUPERINFECTION; SURGICAL INFECTION; SURGICAL WOUND; WOUND CARE; WOUND HEALING;

EID: 77954481371     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Deleo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomic era. J Clin Invest. 2009;119:2464-2474.
2. Chang S, Sievert D, Hageman JC, Boulton ML. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347.
3. Centers for Disease Control and Prevention. http://www. cdc.gov/ncidod/dhqp/ar_mrsa_surveillanceFS.html. Accessed April 22, 2010.
4. Atiyeh BS, Dibo SA, Hayek SN. Wound cleansing, topical antiseptics and wound healing. Int Wound J. 2009;6:420-430.
5. White RJ, Cutting K, Kingsley A. Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage. 2006;52:26-58.
6. Spann CT, Taylor SC, Weinberg JM. Topical antimocrobial agents in dermatology. Dis Mon. 2004;50:407-421.
7. Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis. 2009;49(10):1541-1549.
8. Liu X, Lee PY, Ho CM, et al. Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing. ChemMedChem. 2010;5(3):468-475.
9. James WD. Use of antibiotic-containing ointment versus plain petrolatum during and after clean cutaneous surgery. J Am Acad Dermatol. 2006;55:915-916.
10. Ghaffari A, Jalili R, Ghaffari M, et al. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen. 2007;15(3):368-377.
11. Raghavan M, Linden PK. Newer treatment options for skin and soft tissue infections. Drugs. 2004;64:1621-1642.
12. Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs. 2003;63(14):1459-1480.
13. Schwentker A, Vodovotz Y, Weller R, Billiar T. Nitric oxide and wound repair? Role of cytokines? Nitric Oxide. 2002;7:1-10.
14. Friedman AJ, Han G, Navati MH, et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide. 2008;19:12-20.
15. Miller MR, Megson IL. Recent developments in nitric oxide donor drugs. Br J Pharmacol. 2009;151:305-321.
16. Subczynski WK, Lomnicka M, Hyde JS. Permeability of nitric oxide through lipid bilayer membranes. Free Radic Res. 1996;23:343-349.
17. Weller RB. Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing. J Invest Dermatol. 200;129: 2335-2337.
18. Stallmeyer B, Kampfer H, Kolb N, et al. The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol. 1999;113(6):1090-1098.
19. Schapiro JM, Libby SJ, Fang FC. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc Natl Acad Sci U S A. 2003;100(14):8496-8501.
20. Stevanin TM, Ioannidis N, Mills CE, et al. Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration, catalyzed by cytochromes bo' or bd, from nitric oxide. J Biol Chem. 2000;275:35868-35875.
21. Engelsman AF, Krom BP, Busscher HJ, et al. Antimicrobial effects of an NO-releasing poly(ethylene vinylacetate) coating on soft-tissue implants in vitro and in a murine model. Acta Biomater. 2009;5:1905-1910.
22. Nablo BJ, Prichar HL, Butler RD, et al. Inhibition of implant-associated infections via nitric oxide release. Biomaterials. 2005;26(34):6984-6990.
23. Keefer LK. Nitric oxide (NO)- and nitroxyl(HNO) generating diazeniumdiolates (NONOates): emerging commercial opportunities. Curr Top Med Chem. 2005;5:625-636.
24. Kroncke KD, Suschek CV. Adulterated effects of nitric oxide-generating donors. J Invest Dermatol. 2008;128(2):258-260.
25. Konter J, Möllmann U, Lehmann J. NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds. Bioorg Med Chem. 2008;16(17):8294-8300.
26. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol. 2004;2: 820-832.
27. Weller R, Finnen MJ. The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice. Nitric Oxide. 2006;15:395-399.
28. Fox S, Wilkinson TS, Wheatley PS, et al. NO-loaded Zn(2+)-exchanged zeolite materials: a potential bifunctional anti-bacterial strategy. Acta Biomater. 2010;6(4):1515-1521.
29. Martinez LR, Han G, Chacko M, et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Invest Dermatol. 2009;129:2463-2469.
30. Han G, Martinez LR, Mihu MR, et al. Nitric oxide releasing nanoparticles are therapeutic for Staphylcoccus aureus abscesses in a murine model of infection. PLoS One. 2009;4(11):e7804.
31. Mihu MR, Sandkovsky U, Han GH, et al. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence. 2010;1:1-6.